Cancer
Breast cancer in Nanjing
南京 乳腺癌
6 hospitals in Nanjing
Order: papers led on breast cancer, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for breast cancer: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Nanjing may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 250 papers led
- 47 papers led
- 45 papers ledNo open trial led
- 24 papers ledNo open trial led
- 19 papers ledNo open trial led
- 0 papers ledNo open trial led
Breast cancer in every city Nanjing on the disease page, with the national map
open trials on breast cancer with a hospital in Nanjing
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Nanjing as lead sponsor or study site. 26 of them are led by a hospital in Nanjing. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingA Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
- Phase
- Phase 1/Phase 2
- Started
- 2026-01
- Posted
- Registry
- NCT07281976
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesChangchun, Guangzhou, Harbin, Nanjing, Shenyang, Zhengzhou
- RecruitingA Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- Phase
- Not given
- Started
- 2026-01
- Posted
- Registry
- NCT07347600
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 27 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Guangzhou, Guiyang, Haikou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Taizhou, Weifang, Wuhan, Xi'an, Xiamen, Yangzhou, Zhengzhou
- RecruitingA Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
- Phase
- Phase 3
- Started
- 2026-03
- Posted
- Registry
- NCT07349069
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNanjing, Shanghai
- RecruitingStudy on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib
- Phase
- Phase 2
- Started
- 2026-02
- Posted
- Registry
- NCT07396454
Age 18 years to 70 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingRO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
- Phase
- Phase 2/Phase 3
- Started
- 2026-05
- Posted
- Registry
- NCT07413939
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 22 listed hospitals as study sitesBeijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Nanjing, Nanning, Shanghai, Shantou, Tianjin, Urumqi, Wuhan
- RecruitingBGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
- Phase
- Phase 3
- Started
- 2026-05
- Posted
- Registry
- NCT07492641
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 28 listed hospitals as study sitesBeijing, Bengbu, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Kunming, Nanchang, Nanjing, Nanning, Nantong, Shanghai, Shantou, Shijiazhuang, Tianjin, Weifang, Wenzhou, Wuhan, Xi'an, Zhengzhou
- RecruitingEfficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
- Phase
- Phase 2
- Started
- 2026-03
- Posted
- Registry
- NCT07498478
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 13 listed hospitals as study sitesBeijing, Changsha, Chongqing, Guangzhou, Hangzhou, Jinan, Linyi, Nanjing, Shanghai, Tianjin, Wuhan
- RecruitingQUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer
- Phase
- Phase 2
- Started
- 2026-04
- Posted
- Registry
- NCT07601178
Age 18 years to 75 years (registered criteria)
Led by Jiangsu Cancer HospitalNanjing
- RecruitingFovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
- Phase
- Phase 2
- Started
- 2026-05
- Posted
- Registry
- NCT07616427
Age 18 years to 75 years; women only (registered criteria)
Led by Second Affiliated Hospital, Zhejiang University; 1 listed hospital as study siteHangzhou, Nanjing
- RecruitingA Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
- Phase
- N/A
- Started
- 2026-06
- Posted
- Registry
- NCT07622836
Age 18 years to 75 years (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingBreast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized Trial
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07698366
Age 65 years to 80 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingSMP-656 for HER2-Positive Advanced Breast Cancer
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07726342
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Jinan, Nanjing, Shenyang, Shijiazhuang, Wuhan, Xi'an, Zhengzhou
- RecruitingA Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.
- Phase
- Not given
- Started
- 2026-08
- Posted
- Registry
- NCT07743944
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)
- Phase
- Phase 2
- Started
- 2026-10
- Posted
- Registry
- NCT07876557
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 25 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Guiyang, Harbin, Jinan, Lanzhou, Nanchang, Nanjing, Qingdao, Shenyang, Shijiazhuang, Taiyuan, Weifang, Wuhan, Yinchuan, Zhengzhou
- RecruitingA Prospective, Phase II, Exploratory Study Protocol of a Chemotherapy Sensitivity-based Culmerciclib Combination Regimen in Neoadjuvant Therapy for HR+/HER2- Breast Cancer.
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07900516
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT06757634
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Jinan, Luoyang, Nanchang, Nanjing, Ningbo, Shenyang, Tianjin, Weifang, Xi'an, Xinxiang, Yangzhou, Zhengzhou
- RecruitingTo Evaluate the Effectiveness and Safety of Mastectomy Combined With Immediate Breast Reconstruction in Breast Cancer (NJMU-Reconstruction Cohort)
- Phase
- N/A
- Started
- 2025-01
- Posted
- Registry
- NCT06817954
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingHypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction
- Phase
- N/A
- Started
- 2025-01
- Posted
- Registry
- NCT06830083
Age 18 years to 65 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy
- Phase
- Phase 3
- Started
- 2025-06
- Posted
- Registry
- NCT06830889
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesNanjing, Shanghai
- RecruitingA Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase
- Phase 3
- Started
- 2025-03
- Posted
- Registry
- NCT06841354
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBengbu, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanjing, Nanning, Taiyuan, Taizhou, Urumqi, Wuhan, Xi'an, Xiamen, Xiangyang, Xuzhou, Zhengzhou
- RecruitingA Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase
- Phase 3
- Started
- 2025-06
- Posted
- Registry
- NCT06966700
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Changchun, Changsha, Hangzhou, Harbin, Hefei, Jinan, Nanjing, Nanning, Shanghai, Urumqi, Wuhan, Xi'an, Xiamen, Zhengzhou
- RecruitingA Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
- Phase
- Phase 3
- Started
- 2025-06
- Posted
- Registry
- NCT07003074
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 13 listed hospitals as study sitesChangchun, Changsha, Hefei, Jinan, Nanjing, Shanghai, Shantou, Shenyang, Taiyuan, Tianjin, Urumqi, Wuhan
- RecruitingA Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
- Phase
- Phase 3
- Started
- 2025-09
- Posted
- Registry
- NCT07043725
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 52 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Harbin, Hefei, Hengyang, Jinan, Lanzhou, Linyi, Luoyang, Luzhou, Meizhou, Nanchang, Nanjing, Nanning, Ningbo, Quanzhou, Shanghai, Shantou, Shenyang, Shijiazhuang, Taiyuan, Taizhou, Tianjin, Urumqi, Weifang, Wenzhou, Wuhan, Xi'an, Xinxiang, Yantai, Zhengzhou
- RecruitingJS207 Combination Therapy in Triple-negative Breast Cancer
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07045311
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 18 listed hospitals as study sitesBeijing, Changchun, Dalian, Hangzhou, Harbin, Hefei, Nanjing, Qingdao, Shenyang, Shijiazhuang, Urumqi, Wuhan, Xi'an, Zhengzhou
- RecruitingTQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT07047365
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 44 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Guiyang, Haikou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Luoyang, Luzhou, Nanchang, Nanchong, Nanjing, Nanning, Ningbo, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Tangshan, Tianjin, Weifang, Wenzhou, Xi'an, Xiangyang, Xining, Xinxiang, Xuzhou, Zhengzhou
- RecruitingA Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Phase
- Phase 3
- Started
- 2025-07
- Posted
- Registry
- NCT07060807
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Nanchang, Nanjing, Nanning, Taizhou, Urumqi, Xi'an, Xiamen, Xiangyang, Zhengzhou
- RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Phase
- Phase 3
- Started
- 2025-08
- Posted
- Registry
- NCT07062965
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 23 listed hospitals as study sitesBeijing, Changchun, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Nanning, Shanghai, Shijiazhuang, Wenzhou, Wuhan, Xi'an
- RecruitingProspective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy
- Phase
- Phase 2
- Started
- 2025-01
- Posted
- Registry
- NCT07113613
Age 30 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
- Phase
- Phase 1/Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07169994
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesAnyang, Chengdu, Fuzhou, Guangzhou, Harbin, Hefei, Luoyang, Meizhou, Nanchang, Nanjing, Shanghai, Shenyang, Taiyuan, Tianjin, Xiangyang
- RecruitingAn Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
- Phase
- Phase 1
- Started
- 2025-12
- Posted
- Registry
- NCT07222267
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 10 listed hospitals as study sitesBeijing, Changsha, Chongqing, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Xiamen
- RecruitingEfficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis
- Phase
- Phase 2
- Started
- 2025-10
- Posted
- Registry
- NCT07263425
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingNeoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
- Phase
- Phase 2
- Started
- 2025-01
- Posted
- Registry
- NCT07394387
Age 18 years to 70 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Phase
- Not given
- Started
- 2024-01
- Posted
- Registry
- NCT06210776
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Chengdu, Foshan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Kunming, Luoyang, Nanchang, Nanjing, Nantong, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Taiyuan, Tangshan, Tianjin, Urumqi, Weifang, Xi'an, Xinxiang, Xuzhou, Yinchuan, Zhengzhou, Zhuhai
- RecruitingThe Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
- Phase
- Phase 2
- Started
- 2024-01
- Posted
- Registry
- NCT06254690
Age 18 years to 70 years; women only (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase
- Phase 1/Phase 2
- Started
- 2024-06
- Posted
- Registry
- NCT06324357
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesChangchun, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Zhengzhou
- RecruitingEfficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis
- Phase
- Phase 2
- Started
- 2024-08
- Posted
- Registry
- NCT06543992
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingThe Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
- Phase
- Phase 1
- Started
- 2024-11
- Posted
- Registry
- NCT06770296
Age 18 years to 75 years (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingEffect of Subanesthetic Dose of Esketamine on Sleep Quality
- Phase
- N/A
- Started
- 2024-12
- Posted
- Registry
- NCT06773143
Age 18 years to 65 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingRC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
- Phase
- Phase 2
- Started
- 2024-01
- Posted
- Registry
- NCT07065435
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingDisitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
- Phase
- Phase 2
- Started
- 2024-01
- Posted
- Registry
- NCT07446452
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
- Phase
- Phase 3
- Started
- 2023-06
- Posted
- Registry
- NCT05646862
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesChangchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Tianjin, Wuhan
- RecruitingEvaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Phase
- Phase 3
- Started
- 2023-10
- Posted
- Registry
- NCT05696626
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 57 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hangzhou, Kunming, Lanzhou, Linyi, Luoyang, Luzhou, Meizhou, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Urumqi, Wenzhou, Wuhan, Xi'an, Xiamen, Xiangyang, Xuzhou, Zhengzhou
- RecruitingPyrotinib in Women With High-risk in Early Stage Breast Cancer
- Phase
- Phase 2
- Started
- 2023-04
- Posted
- Registry
- NCT05834764
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingSafety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
- Phase
- Phase 2/Phase 3
- Started
- 2023-09
- Posted
- Registry
- NCT05860465
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming, Luoyang, Nanjing, Shenyang, Shijiazhuang, Tianjin, Xi'an, Yinchuan
- RecruitingEfficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
- Phase
- Phase 2
- Started
- 2023-09
- Posted
- Registry
- NCT05872347
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesAnyang, Beijing, Bengbu, Changchun, Guangzhou, Hangzhou, Harbin, Hefei, Luoyang, Nanjing, Nanning, Shijiazhuang, Tianjin, Urumqi, Wuhan, Xiangyang, Yinchuan, Zhengzhou
- RecruitingOmission of SLNB in CN0 Early Breast Cancer
- Phase
- N/A
- Started
- 2023-06
- Posted
- Registry
- NCT05935150
Age 18 years to 70 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingOmission of ALND in Breast Cancer Patients With Axillary pCR
- Phase
- N/A
- Started
- 2023-09
- Posted
- Registry
- NCT05939830
Age 18 years to 70 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer
- Phase
- Phase 2
- Started
- 2023-11
- Posted
- Registry
- NCT06001086
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteNanjing
- RecruitingA Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
- Phase
- Phase 1/Phase 2
- Started
- 2023-09
- Posted
- Registry
- NCT06064812
Age 18 years to Not stated; women only (registered criteria)
Lead sponsor is not a listed hospital; 18 listed hospitals as study sitesChangchun, Chengdu, Guangzhou, Hangzhou, Hefei, Jinan, Luoyang, Nanjing, Nanning, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou
- RecruitingJSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
- Phase
- Phase 3
- Started
- 2023-12
- Posted
- Registry
- NCT06079983
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 60 listed hospitals as study sitesAnyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Hengyang, Jinan, Kunming, Lanzhou, Linyi, Luoyang, Meizhou, Nanchang, Nanjing, Qingdao, Shanghai, Shantou, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Xiamen, Xiangyang, Xining, Xinxiang, Xuzhou, Zhanjiang, Zhengzhou, Zunyi
- RecruitingEfficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
- Phase
- Phase 2
- Started
- 2023-11
- Posted
- Registry
- NCT06341894
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- RecruitingA Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
- Phase
- Phase 3
- Started
- 2022-01
- Posted
- Registry
- NCT05851014
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 32 listed hospitals as study sitesBengbu, Changchun, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Jinan, Kunming, Linyi, Nanchang, Nanjing, Nanning, Ningbo, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an, Yinchuan, Zhengzhou
- RecruitingEfficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
- Phase
- Not given
- Started
- 2022-10
- Posted
- Registry
- NCT06551220
Age 18 years to 80 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesChangsha, Foshan, Fuzhou, Guangzhou, Hangzhou, Hengyang, Nanjing, Shanghai, Shantou, Shenzhen, Zhuhai
- RecruitingEffect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
- Phase
- Phase 4
- Started
- 2021-06
- Posted
- Registry
- NCT04790305
Age 18 years to 70 years (registered criteria)
Led by Fudan University Shanghai Cancer Center; 26 listed hospitals as study sitesBeijing, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Hefei, Jinan, Nanjing, Ningbo, Qingdao, Shanghai, Shenyang, Shijiazhuang, Suzhou, Wuhan, Xi'an, Yangzhou, Zhengzhou
- Not yet recruitingEffect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
- Phase
- N/A
- Started
- 2026-04
- Posted
- Registry
- NCT07481903
Age 18 years to 75 years; women only (registered criteria)
Led by First Teaching Hospital, Tianjin University of Traditional Chinese Medicine; 3 listed hospitals as study sitesBeijing, Nanjing, Tianjin
- Not yet recruitingComparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC
- Phase
- Not given
- Started
- 2026-05
- Posted
- Registry
- NCT07523789
Age 18 years to Not stated; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingCulmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07745257
Age 18 years to 80 years; women only (registered criteria)
Led by Sun Yat-sen University Cancer Center; 8 listed hospitals as study sitesAnyang, Chengdu, Dalian, Guangzhou, Hangzhou, Nanchang, Nanjing, Shijiazhuang, Zhengzhou
- Not yet recruitingA Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer
- Phase
- N/A
- Started
- 2026-09
- Posted
- Registry
- NCT07782086
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Chengdu, Hefei, Luzhou, Nanjing, Shanghai, Xi'an, Xuzhou
- Not yet recruitingQL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT07113964
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingAerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment
- Phase
- N/A
- Started
- 2024-04
- Posted
- Registry
- NCT06234150
Age 18 years to 65 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingTo Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer
- Phase
- N/A
- Started
- 2024-08
- Posted
- Registry
- NCT06561646
Age 18 years to 75 years; women only (registered criteria)
Led by Jiangsu Province HospitalNanjing
- Not yet recruitingAcupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
- Phase
- N/A
- Started
- 2022-08
- Posted
- Registry
- NCT05460819
Age 18 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteNanjing
- Not yet recruitingStudy of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
- Phase
- N/A
- Started
- 2022-12
- Posted
- Registry
- NCT05613504
Age 30 years to 75 years; women only (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteNanjing
- Enrolling by invitationA Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
- Phase
- Phase 2
- Started
- 2025-08
- Posted
- Registry
- NCT07376629
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 22 listed hospitals as study sitesAnyang, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Nanjing, Shanghai, Shenyang, Suzhou, Taiyuan, Tianjin, Wuhan, Xi'an, Xiamen, Xuzhou
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Nanjing
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated BenQ Hospital of Nanjing Medical University南京明基医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Brain Hospital of Nanjing Medical University南京脑科医院 | none | none | none | none | 45 | none | none | 21 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | 2 | none | none | none | none | none | 5 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Eye Hospital of Nanjing Medical University南京医科大学眼科医院 | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital of Nanjing University南京大学医学院附属鼓楼医院 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital of Nanjing University of Chinese Medicine南京中医药大学附属医院 | none | none | none | 21 | none | 18 | none | none | none | none | none | 2 | 0 | none | none | none | none | none | none | 6 | none | none | none | none | none | none | none | none | none | none | none | 6 | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | 1 | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital, Nanjing Medical University南京医科大学附属口腔医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | |
| Affiliated Hospital, Nanjing University of Chinese Medicine江苏省中西医结合医院 | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Hospital, Nanjing University of Traditional Chinese Medicine江苏省中医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Jiangning Hospital, Nanjing Medical University南京市江宁医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Jiangsu Shengze Hospital of Nanjing Medical University江苏盛泽医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Lianyungang Hospital of Xuzhou Medical University连云港市第一人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | 4 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated People's Hospital of Jiangsu University江苏大学附属人民医院 | none | none | none | 21 | none | none | none | none | none | none | none | 1 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Yancheng Hospital, Southeast University盐城市第三人民医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Children's Hospital of Nanjing Medical University南京市儿童医院 | none | none | none | none | none | none | none | none | 3 | none | none | 1 | none | 151 open | none | none | 1 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | 9 | none | 23 | none | 1 | none | none | 0 | none | none | none | 0 | none | 0 | 2 | 0 | 1 | 0 | none | none | none | none | none | 9 | none | none | 0 | none | none | none | none | |
| Fourth Affiliated Hospital of Nanjing Medical University南京医科大学第四附属医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Gaochun People's Hospital南京市高淳人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangsu Cancer Hospital江苏省肿瘤医院 | 141 open | 252 open | 16 | 26 | 1233 open | 6 | 471 open | 15 | none | none | none | 0 | 0 | none | none | none | none | none | none | 6 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | |
| JiangSu Provincce Hospital江苏省人民医院 | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangsu Province Hospital江苏省人民医院(南医大一附院) | 11 | 368 open | 1175 open | 19923 open | 2335 open | 914 open | 25025 open | 59 | none | 0 | 1 | 4 | 141 open | 82 open | 0 | 246 open | 01 open | 9 | 22 | 8119 open | 1 | 0 | none | none | none | none | none | 4 | 33 open | none | none | 10115 open | 18 | none | none | 2 | none | 10 | none | 4 | none | 1 | none | 1 | 0 | none | 2 | 1 | none | 1 | 0 | 1 | none | 0 | 0 | 0 | 2 | 1 | none | none | none | |
| Jiangsu Provincial People's Hospital江苏省人民医院(南京医科大学第一附属医院) | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jiangyin Hospital, Nanjing University of Chinese Medicine江阴市中医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jinling Hospital东部战区总医院(金陵医院) | none | 9 | 231 open | 201 open | 76 | 113 open | 19 | 24 | none | 0 | none | 14 | 0 | none | none | 41 open | none | none | none | 5 | none | none | 0 | 1 | none | none | 01 open | none | none | none | none | 242 open | 2 | none | none | none | none | 2 | none | 2 | none | none | none | none | none | 5 | 10 | none | none | 0 | none | none | none | 0 | 0 | none | 1 | none | none | none | none | |
| Nanjing Bayi Hospital中国人民解放军第八一医院 | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Chest Hospital | none | none | none | none | 25 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Drum Tower Hospital南京鼓楼医院 | 2 | 13 | 952 open | 1133 open | 811 open | 635 open | 45 | 18 | none | none | none | 8 | 12 | 1 | none | 17 | none | none | none | 20 | none | 2 | none | none | none | 0 | none | 2 | 7 | none | none | 121 open | 8 | 821 open | none | 1 | none | 31 | none | 0 | none | 0 | none | none | 0 | none | 3 | none | none | 0 | 1 | 1 | none | none | 0 | 1 | none | none | none | none | none | |
| Nanjing Drum Town Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing First Hospital南京市第一医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Jiangbei Hospital南京江北医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Pukou District Hospital南京市浦口人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Second Hospital南京市第二医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 3 | 0 | none | none | none | none | none | none | none | none | none | |
| Nanjing Stomatological Hospital南京市口腔医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Nanjing Tianyinshan Hospital南京天印山医院 | none | none | 11 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Affiliated Hospital of Nanjing Medical University南京医科大学第二附属医院 | 0 | none | 191 open | 12 | 23 | 61 open | none | none | none | none | 1 | 3 | 2 | 1 | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | 8 | none | none | none | none | 1 | 1 | none | 1 | none | none | none | none | 1 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Hospital, Nanjing University of Chinese Medicine江苏省第二中医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | |
| Shuyang Hospital, Nanjing University of Chinese Medicine沭阳县中医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Sir Run Run Hospital南京医科大学附属逸夫医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Third Affiliated Hospital of Nanjing University of Chinese Medicine南京市中医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | 16 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Women's Hospital, Nanjing Medical University南京市妇幼保健院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | none | none | none | 1 | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Yancheng First Hospital, Nanjing University盐城市第一人民医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Yancheng TCM Hospital, Nanjing University of Chinese Medicine盐城市中医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Zhongda Hospital, Southeast University东南大学附属中大医院 | none | 18 | 599 open | 211 open | 47 | 22 | 24 | 12 | none | 1 | 0 | 3 | 1 | 2 | 2 | 4 | 0 | none | none | 7 | none | none | none | 1 | none | none | none | none | none | none | none | 34 | 3 | 2 | none | none | none | 1 | none | 1 | none | 0 | none | none | none | none | 3 | none | none | none | 1 | none | 1 | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Nanjing.
- Hepatoblastoma 3
- Osteosarcoma 1
- Neuroblastoma 151 open
- B-cell acute lymphoblastic leukaemia 1
- Haemophilia A 0
- Biliary atresia 9
- Congenital heart disease 23
- Anti-NMDA receptor encephalitis 1
- Idiopathic pulmonary fibrosis 0
- Fabry disease 0
- Duchenne muscular dystrophy 0
- Behçet disease 2
- Alport syndrome 0
- IgA nephropathy 1
- Gaucher disease 0
- Hirschsprung disease 9
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 141 open
- Oesophageal squamous cell carcinoma 252 open
- Hepatocellular carcinoma 16
- Stomach cancer 26
- Lung cancer 1233 open
- Pancreatic cancer 6
- Breast cancer 471 open
- Glioma 15
- Osteosarcoma 0
- Gastrointestinal stromal tumour 0
- Lymphoma 6
- Idiopathic pulmonary fibrosis 0
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 11
- Oesophageal squamous cell carcinoma 368 open
- Hepatocellular carcinoma 1175 open
- Stomach cancer 19923 open
- Lung cancer 2335 open
- Pancreatic cancer 914 open
- Breast cancer 25025 open
- Glioma 59
- Retinoblastoma 0
- Chordoma 1
- Osteosarcoma 4
- Gastrointestinal stromal tumour 141 open
- Neuroblastoma 82 open
- Ewing sarcoma 0
- Multiple myeloma 246 open
- B-cell acute lymphoblastic leukaemia 01 open
- Aplastic anaemia 9
- Haemophagocytic lymphohistiocytosis 22
- Lymphoma 8119 open
- Beta thalassaemia 1
- Haemophilia A 0
- Myasthenia gravis 4
- Moyamoya disease 33 open
- Coronary heart disease 10115 open
- Congenital heart disease 18
- Takayasu arteritis 2
- Idiopathic pulmonary fibrosis 10
- Amyotrophic lateral sclerosis 4
- Fabry disease 1
- Duchenne muscular dystrophy 1
- Behçet disease 0
- IgA nephropathy 2
- Gaucher disease 1
- Osteogenesis imperfecta 1
- Primary biliary cholangitis 0
- Primary sclerosing cholangitis 1
- Hirschsprung disease 0
- Inherited epidermolysis bullosa 0
- Hereditary angioedema 0
- Familial adenomatous polyposis 2
- Leber hereditary optic neuropathy 1
- Oesophageal squamous cell carcinoma 9
- Hepatocellular carcinoma 231 open
- Stomach cancer 201 open
- Lung cancer 76
- Pancreatic cancer 113 open
- Breast cancer 19
- Glioma 24
- Retinoblastoma 0
- Osteosarcoma 14
- Gastrointestinal stromal tumour 0
- Multiple myeloma 41 open
- Lymphoma 5
- Atypical haemolytic uraemic syndrome 0
- Thrombotic thrombocytopenic purpura 1
- IgG4-related disease 01 open
- Coronary heart disease 242 open
- Congenital heart disease 2
- Idiopathic pulmonary fibrosis 2
- Amyotrophic lateral sclerosis 2
- Alport syndrome 5
- IgA nephropathy 10
- Osteogenesis imperfecta 0
- Hirschsprung disease 0
- Inherited epidermolysis bullosa 0
- Familial adenomatous polyposis 1
- Nasopharyngeal carcinoma 2
- Oesophageal squamous cell carcinoma 13
- Hepatocellular carcinoma 952 open
- Stomach cancer 1133 open
- Lung cancer 811 open
- Pancreatic cancer 635 open
- Breast cancer 45
- Glioma 18
- Osteosarcoma 8
- Gastrointestinal stromal tumour 12
- Neuroblastoma 1
- Multiple myeloma 17
- Lymphoma 20
- Haemophilia A 2
- Neuromyelitis optica spectrum disorder 0
- Myasthenia gravis 2
- Moyamoya disease 7
- Coronary heart disease 121 open
- Congenital heart disease 8
- Scoliosis 821 open
- Takayasu arteritis 1
- Idiopathic pulmonary fibrosis 31
- Amyotrophic lateral sclerosis 0
- Fabry disease 0
- Behçet disease 0
- IgA nephropathy 3
- Osteogenesis imperfecta 0
- Primary biliary cholangitis 1
- Primary sclerosing cholangitis 1
- Inherited epidermolysis bullosa 0
- Hereditary angioedema 1
- Nasopharyngeal carcinoma 0
- Hepatocellular carcinoma 191 open
- Stomach cancer 12
- Lung cancer 23
- Pancreatic cancer 61 open
- Chordoma 1
- Osteosarcoma 3
- Gastrointestinal stromal tumour 2
- Neuroblastoma 1
- Thrombotic thrombocytopenic purpura 1
- Coronary heart disease 8
- Hepatic echinococcosis 1
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Behçet disease 1
- IgA nephropathy 1
- Oesophageal squamous cell carcinoma 18
- Hepatocellular carcinoma 599 open
- Stomach cancer 211 open
- Lung cancer 47
- Pancreatic cancer 22
- Breast cancer 24
- Glioma 12
- Retinoblastoma 1
- Chordoma 0
- Osteosarcoma 3
- Gastrointestinal stromal tumour 1
- Neuroblastoma 2
- Ewing sarcoma 2
- Multiple myeloma 4
- B-cell acute lymphoblastic leukaemia 0
- Lymphoma 7
- Thrombotic thrombocytopenic purpura 1
- Coronary heart disease 34
- Congenital heart disease 3
- Scoliosis 2
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Fabry disease 0
- IgA nephropathy 3
- Primary biliary cholangitis 1
- Congenital diaphragmatic hernia 1
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for breast cancer.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Nanjing on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.